Assignee
TACIT THERAPEUTICS INC
US·1 granted patent·6 pending applications·0 citations·filing 2023–2024
Top patents by PatentIndex Score
7 records- 0168US2025051764A1Rna editing via recruitment of spliceosome componentsTACIT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0267US12152239B2RNA editing via recruitment of spliceosome componentsTACIT THERAPEUTICS INC·Filed 2023·Granted Nov 26, 2024·0 cites·13 claims
- 0358US2024209366A1High efficiency trans-splicing for replacement of targeted rna sequences in human cellsTACIT THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0457US2026028381A1Systems and methods for promoting trans-splicingTACIT THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0556US2025290067A1Localization of trans-splicing nucleic acid molecules to and within the cellular nucleusTACIT THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0656US2023340469A1Trans-splicing system for tissue-specific replacement of rna sequencesTACIT THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0753US2025270553A1Stabilization of therapeutic trans-splicing rna molecules in human cellsTACIT THERAPEUTICS INC·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when TACIT THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →